These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11014471)

  • 1. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.
    Grill J; Laithier V; Rodriguez D; Raquin MA; Pierre-Kahn A; Kalifa C
    Eur J Pediatr; 2000 Sep; 159(9):692-6. PubMed ID: 11014471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
    Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
    Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and clinical management of optic pathway glioma.
    Astrup J
    Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset optic pathway tumors in children with neurofibromatosis 1.
    Listernick R; Ferner RE; Piersall L; Sharif S; Gutmann DH; Charrow J
    Neurology; 2004 Nov; 63(10):1944-6. PubMed ID: 15557519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ; Gutmann DH
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1.
    Sylvester CL; Drohan LA; Sergott RC
    Curr Opin Ophthalmol; 2006 Feb; 17(1):7-11. PubMed ID: 16436918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
    Azizi AA; Walker DA; Liu JF; Sehested A; Jaspan T; Pemp B; Simmons I; Ferner R; Grill J; Hargrave D; Driever PH; Evans DG; Opocher E;
    Neuro Oncol; 2021 Jan; 23(1):100-111. PubMed ID: 32628746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J; Schüttauf F; Salamon JM; Kordes U; Friedrich RE; Mautner VF
    Anticancer Res; 2019 Feb; 39(2):827-831. PubMed ID: 30711963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.